Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fuji
Queensland Health
Citi
Chubb
Federal Trade Commission
UBS
Cantor Fitzgerald
Boehringer Ingelheim

Generated: May 23, 2018

DrugPatentWatch Database Preview

CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ciprofloxacin In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Ciprofloxacin In Dextrose 5% In Plastic Container launch?

Ciprofloxacin In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Bedford, Hikma Farmaceutica, Hospira, Inforlife, and Teva Pharms. and is included in seven NDAs.

The generic ingredient in CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER is ciprofloxacin. There are thirty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.
Summary for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Pharmacology for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Medical Subject Heading (MeSH) Categories for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 077888-001 Mar 18, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 078431-001 Nov 18, 2009 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare Corp CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 078024-002 Mar 18, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 077138-001 Mar 18, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
QuintilesIMS
Teva
Baxter
Daiichi Sankyo
Healthtrust
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.